Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L. Anderson, Sharon R. Lewin, Carolin Tumpach et al.|The Journal of Infectious Diseases|2019Cited by 52
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Marc Pellegrini, Youry Kim et al.|Cell Reports Medicine|2023Cited by 40
HIV latency reversing agents act through Tat post translational modificationsGeorges Khoury, Damian F. J. Purcell, Talia M. Mota et al.|Retrovirology|2018Cited by 31
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4 <sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Sharon R. Lewin, Carolin Tumpach et al.|Journal of Virology|2019Cited by 21
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIVMatthew J. Gartner, Michael Roche, Carolin Tumpach et al.|AIDS|2022Cited by 5